Interviews & conversations.

Our CEO & Founder Dr. Wahid Awad presents Rosetta Omics: why the company was created, and how AI and spatial multiomics turn a single patient biopsy into insights that guide precision medicine. He also speaks candidly about the realities of building a deeptech company in health: the difficulty of accessing health data, the strict requirements that come with it, and how hard funding remains for deeptech startups.

• Why Rosetta Omics was created and what it aims to achieve
• Analysing patient biopsies to extract multiomics data
• How precision medicine can change outcomes for patients
• The difficulty of accessing health data and its strict requirements
• Funding realities for deeptech startups

Choose Paris Region's Talent Story: Wahid Awad, originally from Egypt, came to Paris for a short research stint and stayed to build Rosetta Omics, leveraging AI and multiomics to transform cancer care.

• How Paris became Wahid's home
• Journey from academia to entrepreneurship
• Why the Paris Region is ideal for innovation, research and international talent
• How AI and multiomics are reshaping precision oncology

Discover how Deeptech is transforming medicine. In this episode, Wahid Awad shares his vision of life-saving innovations.

• Deeptech transforming medicine, in French
• Vision of life-saving innovations in oncology
• Featured on Europe 1 radio

At STATION F during Les Grandes Tendances de la E-santé, our CEO Dr. Wahid Awad spoke with L'Œil de la E-santé about Rosetta Omics' mission and how we are reshaping precision oncology with AI and multiomics, with the support of Pfizer and WILCO Healthcare through the Pfizer Healthcare Hub France program.

• Helping physicians predict treatment response and make better decisions for patients
• Helping pharma and biotech discover new biomarkers and stratify patients in clinical studies
• Filmed at STATION F during Les Grandes Tendances de la E-santé
• Supported by Pfizer and WILCO Healthcare via the Pfizer Healthcare Hub France

Dr. Wahid Awad and Dr. Muhammad Younis discuss the future of cancer care, featured by the London Biotechnology Show.

• Limitations of standard cancer treatments
• Transformative power of AI, multiomics and spatial biology
• How Rosetta Omics builds predictive models that enhance outcomes and lower costs
• Real-world challenges of clinical adoption

An exclusive conversation with Dr. Wahid Awad on his journey, vision and mission to transform cancer care.

• Personal journey from academia to entrepreneurship
• How losing his father to cancer inspired Rosetta Omics
• Predictive models to improve outcomes and reduce healthcare costs
• Closing words: "You only fail when you give up."

Featured (in French) in ActusPaysBas, Dr. Wahid Awad reflects on his 16-year relationship with the Netherlands and stronger Franco-Dutch collaboration.

• 16-year relationship with the Netherlands since 2008
• Importance of Franco-Dutch public/private collaboration
• Netherlands as a leader in life sciences and translational research
• Strengthening international ties to fight cancer

On the Life Science Success podcast, Dr. Wahid Awad discusses how AI and spatial multiomics are reshaping cancer care.

• How AI and spatial multiomics reshape cancer care
• Personal journey from academia to entrepreneurship
• Challenges of bringing precision oncology to patients worldwide
• Why international collaboration is key to scaling innovation

Dr. Wahid Awad spoke at a webinar dedicated to advancing cancer diagnostics and drug development.

• Seamless integration into standard clinical biopsy procedure
• Actionable insights for oncologists in treatment decisions
• Identification of biomarkers of clinical interest
• Support for new drug-target discovery and innovation